Newsroom · source-verified
Follow the evidence. Then tell the story.
Publications, collaboration milestones and company news—organized by source and labeled by evidence type.
Latest milestone
16 · 07 · 2026
Peer reviewed
Frontiers in Pain Research
A translational roadmap for RNA biomarkers in neuropathic pain.
The review brings a clinician and neuroscience perspective to candidate RNA biomarkers, study design, analytical validation and treatment-monitoring questions. It is a review of the field—not a report of a new clinical trial.
Open the paper ↗
Verified milestones
News with its source attached.
Dates, evidence types and external links are preserved so the design team can distinguish released facts from future-facing copy.
July 23, 2026
Publication announcement
Lilac and Soin announce clinical review on RNA biomarkers for neuropathic pain
The announcement follows publication of a peer-reviewed clinical review in Frontiers in Pain Research.
Read the announcement ↗
July 16, 2026
Peer-reviewed clinical review
New insight into RNA biomarkers in neuropathic pain
A clinician–neuroscientist roadmap to translational testing and treatment monitoring, published in Frontiers in Pain Research.
Read the publication ↗
June 22, 2026
Brown University profile
New start-up aims to boost RNA insights worldwide
Brown profiles Lilac as an outgrowth of the Giuliani RNA Center and describes its RNA analytical platforms, services and partnerships.
Read at Brown ↗
February 13, 2026
Collaboration announcement
Soin and Lilac launch RNA-signature study in pain and neuromodulation
The collaborators describe a planned preclinical study of RNA expression under defined spinal cord stimulation conditions.
Read the release ↗
Editorial accuracy
Three distinctions to preserve.
Review ≠ trial
The July paper synthesizes evidence and proposes a roadmap. It does not report validation of a Lilac diagnostic test.
Candidate ≠ validated biomarker
Candidate RNA signals require analytical validation, controlled studies and independent replication.
Research ≠ clinical claim
Neuromodulation work is presented as preclinical and investigational unless a released source states otherwise.
Media & partnerships